Chihiro Nozaki Selected Research

Chihiro Nozaki Research Topics

Disease

9	Hyperalgesia 01/2019 - 11/2005
7	Pain (Aches) 01/2019 - 06/2011
6	Neuralgia (Stump Neuralgia) 01/2019 - 12/2006
4	Chronic Pain 09/2012 - 06/2011
2	Hypersensitivity (Allergy) 07/2011 - 06/2011
1	Jaundice (Icterus) 01/2020
1	Migraine Disorders (Migraine) 08/2015
1	Secondary Headache Disorders 08/2015
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 10/2011
1	Substance-Related Disorders (Drug Abuse) 10/2011
1	Brain Diseases (Brain Disorder) 10/2011
1	Cough 07/2007
1	Painful Neuropathy 04/2006

Drug/Important Bio-Agent (IBA)

3	Opioid Analgesics (Opioids)IBA 09/2012 - 06/2011
3	delta Opioid Receptors (delta Opioid Receptor)IBA 10/2011 - 12/2006
2	LeptinIBA 01/2019 - 07/2018
2	CannabinoidsIBA 01/2019 - 07/2018
2	Leptin ReceptorsIBA 01/2019 - 07/2018
2	CB2 Cannabinoid ReceptorIBA 01/2019 - 07/2018
2	EndocannabinoidsIBA 07/2018 - 08/2015
2	4- (alpha- (4- allyl- 2,5- dimethyl- 1- piperazinyl)- 3- methoxybenzyl)- N,N- diethylbenzamideIBA 09/2012 - 06/2011
2	Freund's AdjuvantIBA 09/2012 - 06/2011
2	Capsaicin (Zostrix)FDA Link 07/2011 - 07/2007
2	Opioid Receptors (Opioid Receptor)IBA 06/2011 - 12/2006
2	Oxycodone (Oxycontin)FDA LinkGeneric 03/2006 - 11/2005
2	Streptozocin (Streptozotocin)FDA Link 03/2006 - 11/2005
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	Fetal Hemoglobin (Hemoglobin F)IBA 01/2020
1	Neutralizing AntibodiesIBA 07/2018
1	Membrane Transport Proteins (Biological Pump)IBA 08/2015
1	anandamide (arachidonylethanolamide)IBA 08/2015
1	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 08/2015
1	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 08/2015
1	EnzymesIBA 08/2015
1	Nitroglycerin (Dynamite)FDA LinkGeneric 08/2015
1	Monoacylglycerol LipasesIBA 08/2015
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 08/2015
1	Analgesics (Analgesic Drugs)IBA 09/2012
1	benzamideIBA 09/2012
1	BenzopyransIBA 09/2012
1	N,N- diethyl- 3- hydroxy- 4- (spiro(chromene- 2,4'- piperidine)- 4- yl)benzamideIBA 09/2012
1	piperidineIBA 09/2012
1	N,N- diethyl- 4- (5- hydroxyspiro(chromene- 2,4'- piperidine)- 4- yl)benzamideIBA 09/2012
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 07/2011
1	ZincIBA 07/2011
1	Formaldehyde (Formol)FDA Link 06/2011
1	Citric Acid (Citrate)FDA LinkGeneric 07/2007
1	Cyclin-Dependent Kinase 5IBA 07/2007
1	RoscovitineIBA 07/2007
1	Naloxone (Narcan)FDA LinkGeneric 12/2006
1	Serotonin (5 Hydroxytryptamine)IBA 12/2006
1	Fluvoxamine (Luvox)FDA LinkGeneric 12/2006
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 12/2006
1	mu Opioid Receptors (mu Opioid Receptor)IBA 12/2006
1	beta-funaltrexamineIBA 12/2006
1	Narcotic Antagonists (Opioid Antagonists)IBA 12/2006
1	Sodium Channels (Sodium Channel)IBA 04/2006
1	Vincristine (Oncovin)FDA LinkGeneric 04/2006
1	Mexiletine (Mexitil)FDA LinkGeneric 04/2006
1	Tetrodotoxin (Tetradotoxin)IBA 04/2006
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2006
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 04/2006

Therapy/Procedure

3	Ligation 09/2012 - 12/2006
2	Analgesia 07/2011 - 06/2011
1	Drug Therapy (Chemotherapy) 08/2015